2021年最新SCI期刊影响因子查询系统
ANTIOXIDANTS & REDOX SIGNALING 期刊详细信息
基本信息
期刊名称 | ANTIOXIDANTS & REDOX SIGNALING ANTIOXIDANTS & REDOX SIGNALING |
---|---|
期刊ISSN | 1523-0864 |
期刊官方网站 | http://www.liebertpub.com/overview/antioxidants-and-redox-signaling/4/ |
是否OA | 否 |
出版商 | Mary Ann Liebert Inc. |
出版周期 | Semimonthly |
始发年份 | 1999 |
年文章数 | 167 |
最新影响因子 | 7.468(2021) |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
生物2区 | BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学2区 | 否 | 否 |
ENDOCRINOLOGY & METABOLISM 内分泌学与代谢2区 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 6.04 | 2.151 | 1.396 |
Biochemistry, Genetics and Molecular Biology Clinical Biochemistry |
2 / 115 | 98% |
|||
Biochemistry, Genetics and Molecular Biology Physiology |
12 / 167 | 93% |
|||
Biochemistry, Genetics and Molecular Biology Biochemistry |
27 / 407 | 93% |
|||
Biochemistry, Genetics and Molecular Biology Cell Biology |
27 / 265 | 90% |
|||
Biochemistry, Genetics and Molecular Biology Molecular Biology |
37 / 375 | 90% |
补充信息
自引率 | 4.90% |
---|---|
H-index | 143 |
SCI收录状况 |
Science Citation Index
Science Citation Index Expanded |
官方审稿时间 | |
网友分享审稿时间 | 数据统计中,敬请期待。 |
PubMed Central (PML) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1523-0864%5BISSN%5D |
投稿指南
期刊投稿网址 | http://www.liebertpub.com/forauthors/antioxidants-and-redox-signaling/4/ |
---|---|
收稿范围 | Antioxidants & Redox Signaling (ARS) is the leading peer-reviewed journal dedicated to understanding the vital impact of oxygen and oxidation-reduction (redox) processes on human health and disease. The Journal explores key issues in genetic, pharmaceutical, and nutritional redox-based therapeutics. Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas. ARS has expanded to create two unique foci within one journal: ARS Discoveries and ARS Therapeutics. ARS Discoveries (24 issues) publishes the highest-caliber breakthroughs in basic and applied research. ARS Therapeutics (12 issues) is the first publication of its kind that will help enhance the entire field of redox biology by showcasing the potential of redox sciences to change health outcomes. ARS coverage includes: ROS/RNS as messengers Gaseous signal transducers Hypoxia and tissue oxygenation microRNA Prokaryotic systems Lessons from plant biology ARS is under the editorial leadership of Editor-in-Chief Chandan K. Sen, PhD, Indiana University School of Medicine, and other leading investigators. View the entire editorial board. Audience: Cell biologists, molecular biologists, biochemists, medical researchers, and nutritionists, among others. |
收录体裁 | |
投稿指南 | |
投稿模板 | |
参考文献格式 | |
编辑信息 |